Patrick D. Walsh steps down as Chairman of ANI Pharmaceuticals, Inc. and will complete his current term as a Board member.
Thomas J. Haughey has been unanimously elected to serve as the next Chairman of the Board.
Mr. Walsh's retirement will be effective after completing his current term through the Company's 2026 Annual Meeting of Stockholders.
Board Transition
Patrick D. Walsh steps down as Chairman, Thomas J. Haughey elected as the next Chairman.
Leadership Change
Mr. Haughey to lead as Chairman, emphasizing patient support and profitable growth.
Commitment to Patients
ANI Pharmaceuticals remains committed to serving patients and improving lives through innovative therapeutics.
- The transition in the Chairman position marks a significant change in ANI Pharmaceuticals' leadership structure.
- This move reflects the Company's focus on sustainable growth and continued support for patients in need.
The appointment of Thomas J. Haughey as the next Chairman reflects ANI Pharmaceuticals' dedication to driving sustainable growth and supporting patients in various therapeutic areas. The Company is poised for continued advancement under his leadership.